Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Cuprina Holdings Cayman Limited's Business Segments

Cuprina Holdings Cayman Limited's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY

Reportable Segments

Per the company's own filing, this quarter

Largest Segment

Maggot Debridement Therapy Product

87.7% of revenue

Total Revenue

$ 0

Consolidated, this quarter

Regions Reported

Geographic regions, this quarter

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/CUPR/segments                    

                        https://api.csimarket.com/api/v1/companies/CUPR/geographic                    

                        https://api.csimarket.com/api/v1/companies/CUPR/exposure                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Revenue Share by Reportable Segment - FY

Maggot Debridement Therapy Product87.7%
Cosmeceutical Product10.3%

Revenue by Reportable Segment - FY

Segment	Period	Revenue (Millions)	% of Total	Operating Income
Maggot Debridement Therapy Product	FY	$ 0	87.7%	-
Cosmeceutical Product	FY	$ 0	10.3%	-

Annual Results

Revenue Share by Reportable Segment - FY2025

Maggot Debridement Therapy Product0%
Cosmeceutical Product15.5%

Revenue by Reportable Segment - FY2025

Segment	Period	Revenue (Millions)	% of Total	Operating Income
Maggot Debridement Therapy Product	FY2025	$ 0	-	-
Cosmeceutical Product	FY2025	$ 0	15.5%	-

Description of Cuprina Holdings Cayman Limited

The Company operates two reportable segments: Maggot Debridement Therapy Product and Cosmeceutical Product. The Chief Executive Officer, serving as the chief operating decision maker (CODM), reviews consolidated results for resource allocation and performance assessment. The Company's assets are located in Singapore, Malaysia, and the United States, with revenue primarily generated from operations in Singapore.